Blog

  • New to The Street TV Commercial Campaigns Achieve Millions of Views with 87% Average Completion Rate

    New to The Street TV Commercial Campaigns Achieve Millions of Views with 87% Average Completion Rate

    Cross-platform synergy across NTTS TV, cable, social media, and NewsOut video press release amplification is delivering record-breaking visibility for public companies

    NEW YORK CITY, NEW YORK / ACCESS Newswire / August 3, 2025 / New to The Street, the nationally recognized financial television platform, is redefining public company visibility with its high-performance commercial campaigns, now averaging millions of views and achieving an industry-leading 87% average view completion rate. By fusing national TV broadcasting, cable airtime, YouTube distribution, social media amplification, and its expanding partnership with NewsOut, the platform delivers one of the most effective multi-channel strategies in financial media today.

    A standout example is ARRIVE AI ($ARAI), which garnered over 566,000 views on YouTube for its campaign featured on New to The Street TV.
    View the segment: https://youtu.be/m1T_6WCVjPo?si=pPxTYW8wQQC3qWAw

    Other high-performing campaigns include:

    Each of these campaigns was fully produced and managed in-house by New to The Street, ensuring consistent branding, high production value, and seamless integration across all media channels.

    “We are seeing the cross-platform approach we use for TV commercials-by combining our linear TV shows, cable placements, YouTube distribution, and social media channels-as an extreme advantage for our clients,” said Vince Caruso, Co-Founder and CEO of New to The Street. “The results have been astonishing. And now, with our growing partnership with NewsOut, we’re extending that impact through a smart, scalable video PR engine that delivers immediate traction with measurable ROI.”

    The Cross-Platform Media Engine Includes:

    • Broadcast exposure on Bloomberg, Fox Business, and syndicated regional cable

    • YouTube distribution to over 3.2 million subscribers

    • Social amplification across LinkedIn, Twitter (X), Instagram, and Facebook

    • Earned media pickup by ABC, NBC, and CBS affiliates

    • Iconic outdoor visibility across Times Square billboards and NYC Financial District

    • NewsOut partnership enabling rapid video press release syndication across financial media and investor channels

    About New to The Street

    With more than 600 episodes produced, New to The Street is one of the longest-running U.S. financial television programs. Broadcasting nationwide on Bloomberg, Fox Business, and more, it delivers long-form interviews, short-form commercials, and integrated exposure across digital, social, and outdoor platforms. All creative and commercial production is managed fully in-house, ensuring brand alignment, speed to market, and media ROI.

    About NewsOut

    NewsOut is a next-generation video press release platform built to amplify company news through professional production, YouTube distribution, financial media partnerships, social amplification, and targeted investor email blasts. As a strategic partner of New to The Street, NewsOut extends client campaigns to broader financial audiences with measurable impact.

    https://youtube.com/@newsoutchannel?si=IImxJQQn_1mgAPKR

    For more information, visit: www.NewToTheStreet.com
    Media Contact: Grace@NewToTheStreet.com

    SOURCE: New to The Street

    View the original press release on ACCESS Newswire

    The post New to The Street TV Commercial Campaigns Achieve Millions of Views with 87% Average Completion Rate appeared first on Local News Hub.

  • Copyfast Printing Expands Same-Day Print Services in Scottsdale, Strengthening Support for Local Businesses

    Copyfast Printing Expands Same-Day Print Services in Scottsdale, Strengthening Support for Local Businesses

    Copyfast Printing, a trusted name in the Scottsdale print industry for nearly four decades, has announced the expansion of its same-day printing services. This development comes as part of the company’s ongoing mission to meet the evolving needs of Arizona businesses, organizations, and individuals who rely on fast, reliable print solutions.

    Since its founding in Scottsdale, Copyfast Printing has grown into the best full-service print shop offering a wide array of services—from digital printing and large-format banners to professionally finished brochures, business cards, and marketing materials. Known for its consistency, speed, and customer-first approach, the company has built a reputation for delivering both quality and efficiency across every order.

    Tom Lafata, a representative of Copyfast Printing, shared insight into the expansion. “We’ve always prioritized convenience and quality for our clients. The ability to deliver same-day turnaround on core products like business cards, flyers, and posters is another step forward in helping businesses move faster without sacrificing print standards.”

    The newly expanded same-day printing service applies to many of the company’s most in-demand products. When submitted before the daily cutoff time, eligible orders can be printed, finished, and ready for pickup or delivery by the end of the same business day. This offering is powered by recent equipment upgrades and process optimizations, allowing the team to increase output speed while maintaining the high-resolution quality Copyfast is known for.

    In addition to digital and offset printing, Copyfast offers a full range of finishing services, including folding, laminating, saddle-stitching, and custom cutting. These enhancements are also supported under the same-day service model for qualifying jobs, ensuring that last-minute projects still receive professional presentation.

    Copyfast Printing’s Scottsdale location also serves nearby communities such as Tempe, Paradise Valley, and Old Town Scottsdale, which are frequent hubs for trade shows, conferences, and pop-up events. With this expansion, local businesses and event organizers can now rely on Copyfast for last-minute materials without compromising their branding or timelines.

    Beyond production, the company also offers in-house graphic design services. Clients can consult with Copyfast’s design team to ensure artwork is optimized for print, which is particularly helpful for rush orders that require clean, press-ready files.

    Another area of growth has been in direct mail services, where same-day printing can now be paired with timely neighborhood targeting for political mailers, promotional postcards, and retail campaigns. This turnkey solution allows clients to go from design to mailbox with minimal delays—streamlining the entire print and distribution process.

    Looking ahead, Copyfast Printing plans to continue investing in new technology and staff development to support its growing customer base. The company’s leadership believes that speed and service must go hand-in-hand, especially in today’s fast-paced commercial landscape.

    “Our goal has always been to offer printing that supports business momentum,” said Lafata. “Whether it’s a startup getting materials ready for launch or a nonprofit preparing for an event, we want to be the print partner they can count on—even when time is tight.”

    As Copyfast Printing celebrates 39 years in business, this service expansion marks another step in its long-standing commitment to Scottsdale and the surrounding communities. By combining modern equipment, local expertise, and a dedication to fast service, the company continues to position itself as a leader in Arizona’s commercial print space.

    For more information on same-day printing or other services, visit the Copyfast Printing website or contact the shop directly, or review their last news about how Copyfast Printing Celebrates 38 Years In Scottsdale.

    The post Copyfast Printing Expands Same-Day Print Services in Scottsdale, Strengthening Support for Local Businesses appeared first on Local News Hub.

  • Arrowhead Clinic in Riverdale, GA Celebrates Milestone with Over 950 Five-Star Reviews, Shining in Personal Injury Care

    Arrowhead Clinic in Riverdale, GA Celebrates Milestone with Over 950 Five-Star Reviews, Shining in Personal Injury Care

    Arrowhead Clinic, a top chiropractic center located in Riverdale, Georgia, recently celebrated a big win by reaching over 950 five-star reviews on Google. This milestone reflects the clinic’s long-standing commitment to offering outstanding care for patients dealing with auto accidents and other personal injuries. Arrowhead Clinic is known for its wide range of services, from diagnostic tools to specialized treatments tailored for various accident-related injuries. For detailed information about the services offered, visit the Arrowhead Clinic Riverdale GA Location webpage.

    The clinic credits its positive reputation to the dedication and skill of its team, led by Dr. Calvin Erhabor. “We are extremely grateful to our patients for taking the time to share their positive experiences,” said Dr. Erhabor. “Our team’s main goal is to deliver personalized care that caters to each individual’s recovery needs.” More insights into their treatment plans and patient experiences can be found on their clinic blog.

    Dr. Calvin Erhabor Riverdale Georgia Chiropractor

    Arrowhead Clinic provides an array of treatment options for injuries from car, truck, and motorcycle accidents, as well as for workplace and sports injuries. They use advanced diagnostic techniques to pinpoint the sources of injuries, allowing them to create precise, personalized treatment plans. Additionally, Arrowhead Clinic offers specialized care for specific incidents like truck accident injury treatment.

    Beyond medical care, Arrowhead Clinic helps patients navigate legal issues by connecting them with respected personal injury attorneys. Patients seeking legal guidance can explore their personal injury attorney referral service.

    Positioned on Upper Riverdale Road, the clinic is open six days a week. This schedule gives patients flexibility in choosing appointment times. Understanding that patients have diverse needs, Arrowhead Clinic focuses on specific care for common auto accident injuries like whiplash and back pain. Resources such as their chiropractor care guide offer valuable information to those recovering from such injuries. This focused care, along with high-quality service, contributes to their excellent rating.

    Dr. Erhabor highlights the role of the community and patient feedback in the clinic’s development: “Our clinic’s growth and success are a direct result of the trust our patients have in us. We strive to maintain this trust by continuously improving our service and patient care.”

    The Riverdale clinic is part of a larger network of Arrowhead Clinics throughout Georgia, all offering a broad range of services designed to meet community needs. Every location seeks to deliver the same superb level of quality and care that has earned the Riverdale clinic its outstanding reputation.

    Beyond their primary services, Arrowhead Clinic offers resources like blogs and guides on chiropractic care and post-accident recovery. These materials aim to educate and empower patients by providing key information about their conditions and treatment options. Furthermore, Arrowhead Clinic’s referral network includes experienced personal injury lawyers.

    For more than 48 years, Arrowhead Clinic in Riverdale has been dedicated to high-quality chiropractic care. Surpassing 950 positive reviews highlights their significant impact and commitment to the community. Their continuous effort to improve patient outcomes solidifies their role as a vital resource for injury recovery in the Riverdale area and beyond.

    Regardless of the type of injury, Arrowhead Clinic is committed to assisting patients in their recovery journey and helping them reclaim their quality of life. The clinic is continually enhancing its services and support for patients, focusing on both immediate needs and long-term care.

    For anyone seeking help with personal injury recovery, the Arrowhead Clinic Riverdale GA Location offers a welcoming setting where patients receive expert care tailored to their individual needs. As they continue to build on their legacy of excellent service, they reaffirm their commitment to the health and well-being of their community, demonstrating Arrowhead Clinic’s dedication to outstanding chiropractic and medical care.

    The post Arrowhead Clinic in Riverdale, GA Celebrates Milestone with Over 950 Five-Star Reviews, Shining in Personal Injury Care appeared first on Local News Hub.

  • AccreditedEvents and New to The Street Host Exclusive Investor Cocktail Event Featuring MUSQ ($MUSQ), The Music ETF, on September 3 at Hudson Yards

    AccreditedEvents and New to The Street Host Exclusive Investor Cocktail Event Featuring MUSQ ($MUSQ), The Music ETF, on September 3 at Hudson Yards

    New to The Street Host Exclusive Investor Cocktail Event Featuring MUSQ ($MUSQ), The Music ETF, on September 3 at Hudson Yards

    NEW YORK, NY / ACCESS Newswire / August 1, 2025 / AccreditedEvents, in partnership with New to The Street, proudly announces an exclusive investor cocktail event spotlighting MUSQ ($MUSQ), the innovative Music ETF. The event will take place Wednesday, September 3, 2025, from 6:00 pm to 8:00 pm at Hudson Yards in New York City.

    This invitation-only event offers accredited investors and financial industry professionals a rare and intimate opportunity to meet David Schulhof, Founder and CEO of MUSQ Global Music Industry ETF, along with select senior executives from the world’s leading music and entertainment companies possibly including:

    • Spotify

    • Live Nation

    • Universal Music Group

    • Tencent Music

    • CTS Eventim

    • Apple Music

    • YouTube

    • Amazon Music

    • Warner Music

    • Reservoir Media

    Guests will have the chance to engage directly with these industry leaders and gain valuable insights into MUSQ’s innovative approach to music industry investments, current market trends, and future growth opportunities.

    “We’re delighted to present this exceptional event at Hudson Yards featuring MUSQ,” stated Vince Caruso, Director of AccreditedEvents and Founder of New to The Street. “MUSQ is uniquely positioned to capture investor interest by strategically tapping into the thriving global music sector, and this event underscores our commitment to connecting sophisticated investors with pioneering investment opportunities.”

    The event will commence with an engaging presentation by MUSQ executives, followed by an interactive Q&A session and networking reception, providing attendees the ideal environment to explore alternative investments and build connections with prominent thought leaders in the music and entertainment space.

    Event Details:

    • Date: Wednesday, September 3, 2025

    • Time: 6:00 pm – 8:00 pm

    • Location: Hudson Yards, NYC

    Space is limited, and attendance is strictly by invitation. Accredited investors and financial professionals interested in attending are encouraged to RSVP promptly.

    For further details or to secure your invitation, please contact:
    Vince Caruso
    Vince.Caruso@NewtoTheStreet.com

    About Accredited Events:
    AccreditedEvents specializes in curated, invitation-only networking and educational events designed specifically for accredited investors, connecting them with innovative companies and exclusive investment opportunities across a variety of sectors.

    About New to The Street:
    New to The Street is a leading multimedia financial news and content provider dedicated to showcasing innovative, emerging growth companies to investors. Leveraging national television platforms, digital channels, and exclusive events, New to The Street delivers unmatched exposure through sponsored programming on Bloomberg Television and Fox Business, complemented by a robust social media presence.

    Upcoming AccreditedEvents in September and October (Dates T.B.A.):

    • NeOnc Technologies ($NTHI)

    • DataVault Holdings ($DVLT)

    • Synergy CHC ($SNYR)

    • NRx Pharmaceuticals ($NRXP)

    • Health In Tech ($HIT)

    • NewsOut (Private Company)

    About MUSQ LLC: MUSQ LLC is the mastermind behind the MUSQ Global Music Industry Index (MUSQIX), and the MUSQ Global Music Industry ETF (NYSE:MUSQ). MUSQ LLC’s founder and CEO, David Schulhof, is an experienced music investor and operator with more than 25 years of investing in and operating public and private companies in the music and entertainment industry.

    For more information, please contact: info@musq.com

    For a complete list of MUSQ holdings and sector breakdown, please visit musqetf.com. Holdings subject to change. Source: Yang, Lisa, et al., Music in the Air, Goldman Sachs Equity Research, May 01, 2024.

    MUSQ Global Music Industry ETF is offered by prospectus. Carefully consider the investment objectives, risks, charges, and expenses. This and other important information can be found in the MUSQ ETF prospectus, which should be read carefully before investing and can be obtained by visiting https://musqetf.com or by calling 1-855-MUSQ-ETF (687-7383).

    SOURCE: New To The Street

    View the original press release on ACCESS Newswire

    The post AccreditedEvents and New to The Street Host Exclusive Investor Cocktail Event Featuring MUSQ ($MUSQ), The Music ETF, on September 3 at Hudson Yards appeared first on Local News Hub.

  • D. Boral ARC Acquisition I Corp. Announces Closing of $250,000,000 Initial Public Offering

    D. Boral ARC Acquisition I Corp. Announces Closing of $250,000,000 Initial Public Offering

    NEW YORK CITY, NEW YORK / ACCESS Newswire / August 1, 2025 / D. Boral ARC Acquisition I Corp. (the “Company”) today announced the closing of its initial public offering of 25,000,000 units at a price of $10.00 per unit for total gross proceeds of $250,000,000. The units began trading on The Nasdaq Global Market under the ticker symbol “BCARU” on July 31, 2025. Each unit consists of one of the Company’s Class A ordinary shares and one-half of one redeemable public warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be traded on The Nasdaq Global Market under the symbols “BCAR” and “BCARW,” respectively.

    The Company has granted the underwriters a 45-day option to purchase up to 3,750,000 additional units at the initial public offering price to cover over-allotments, if any, which, if exercised in full, would bring the total gross proceeds of the offering to $287,500,000.

    The Company intends to use the net proceeds from the offering and the simultaneous private placement of units to pursue and consummate a business combination with one or more businesses.

    D. Boral Capital LLC acted as sole book-running manager for the offering.

    Loeb & Loeb LLP acted as legal counsel to the Company and Paul Hastings LLP acted as legal counsel to D. Boral Capital LLC.

    The offering was made only by means of a prospectus. Copies of the prospectus relating to the offering may be obtained from D. Boral Capital LLC: Attn: 590 Madison Avenue 39th Floor, New York, NY 10022, or by email at info@dboralcapital.com, or by telephone at (212) 970-5150, or from the U.S. Securities and Exchange Commission’s (the “SEC”) website at www.sec.gov.

    A registration statement on Form S-1 relating to these securities was declared effective by the SEC on July 30, 2025. This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

    About D. Boral ARC Acquisition I Corp.

    The Company was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an acquisition opportunity in any business, industry, sector or geographical location, the Company intends to identify and acquire a business where the Company believes its management teams’ and affiliates’ expertise will provide a competitive advantage, including the technology, healthcare, and logistics industries.

    Forward-Looking Statements

    This press release contains statements that constitute “forward-looking statements,” including with respect to the underwriters’ exercise of the over-allotment option, the anticipated use of the net proceeds from the IPO and the search for an initial business combination. No assurance can be given that the net proceeds of the offering will be used as indicated or that the Company will ultimately complete a business combination transaction in the sectors it is targeting or at all. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and prospectus for the IPO filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

    Contact

    John Darwin, Chief Financial Officer
    Email: contact@arc-group.com

    SOURCE: D. Boral Capital

    View the original press release on ACCESS Newswire

    The post D. Boral ARC Acquisition I Corp. Announces Closing of $250,000,000 Initial Public Offering appeared first on Local News Hub.

  • Sun Capital Welcomes New Equity Partner Zeze Sun, Following $22.7M Strategic Acquisition of Irvine Medical Management

    Sun Capital Welcomes New Equity Partner Zeze Sun, Following $22.7M Strategic Acquisition of Irvine Medical Management

    NEW YORK, NY / ACCESS Newswire / August 1, 2025 / In a key leadership move, following a strategic U.S. healthcare acquisition, Sun Capital Partners has officially named Zeze Sun as the new Equity Partner. The promotion comes after recognizing Sun for his instrumental role in the firm’s recent M&A transaction with Irvine Medical Management, which is the parent company of Anaheim Surgery Center and A&C Urgent Care. Sun’s leadership abilities and tenacious initiative helped spark a significant expansion of Sun Capital’s overall operational footprint within the outpatient surgery sector.

    “This transaction is a strategic inflection point not just for our portfolio, but for how we integrate legal, financial, and healthcare expertise into a unified growth platform,” said Zeze Sun. “I’m honored to step into this expanded role at such a pivotal time.”

    Sun has also led the legal team that is responsible for full-spectrum regulatory diligence, deal structuring, and cross-border transaction execution, which ultimately has guided the firm through a complex and high-value healthcare acquisition.

    Dr. Gary Y. Chen, MS, M.D., CEO of Anaheim Surgery Center Medical Group and Clinical Professor of Orthopedic Surgery at UCLA, who is formerly a microsurgery professor at Johns Hopkins University’s renowned Curtis National Hand Center – also praised Sun’s leadership record.

    “Sun’s strategic vision and deep understanding of the healthcare legal landscape was critical to making this acquisition both seamless and forward-thinking,” said Dr. Gary Chen.

    The acquisition aligns with Sun Capital‘s consistent strategy to scale high-performance assets in healthcare, with an emphasis on surgical efficiency, regulatory compliance, and digital integration. The capital firm is positioning itself to be a leading investor in the evolving U.S. outpatient medical landscape.

    In recent years, Sun Capital has evolved into a family office that operates as a seasoned private equity firm, with significant committed capital and a diverse portfolio that spans across healthcare, legal services, accounting, media, and other regulated sectors. The firm primarily targets middle-market businesses with EBITDA between $20 million and $100 million, by applying an “operations-first” investment philosophy that blends financial discipline with hands-on operational expertise.

    “Zeze Sun possesses a rare ability to execute complex transactions, while navigating diverse regulatory landscapes,” said Jeff Conway, Senior Contributor for Forbes.

    Sun’s expertise will play a pivotal role in driving complex transactions and unlocking new value. With a global platform built on integration, execution, and long-term vision, Sun Capital is firmly positioned to shape the future of private equity investment.

    To get in touch with Sun Partners, please email info@sunpartnerspc.com

    SOURCE: Sun & Partners

    View the original press release on ACCESS Newswire

    The post Sun Capital Welcomes New Equity Partner Zeze Sun, Following $22.7M Strategic Acquisition of Irvine Medical Management appeared first on Local News Hub.

  • New to The Street Show #682 Premieres on Bloomberg Tonight Featuring Industry Leaders: DataVault, PetVivo, Health In Tech, FLOKI, and NRx Pharma Backed by National TV Commercials and Outdoor Campaigns Sponsored by MUSQ, ArriveAI, and Sustainable Green Team

    New to The Street Show #682 Premieres on Bloomberg Tonight Featuring Industry Leaders: DataVault, PetVivo, Health In Tech, FLOKI, and NRx Pharma Backed by National TV Commercials and Outdoor Campaigns Sponsored by MUSQ, ArriveAI, and Sustainable Green Team

    Backed by National TV Commercials and Outdoor Campaigns Sponsored by MUSQ, ArriveAI, and Sustainable Green Team

    NEW YORK CITY, NEW YORK / ACCESS Newswire / August 1, 2025 / New to The Street, the nation’s leading financial media platform, proudly announces the broadcast of Show #682, airing this evening at 9:30 PM PST on Bloomberg Television as sponsored programming. This episode showcases transformative companies driving innovation across artificial intelligence, veterinary health, blockchain, healthcare SaaS, and pharmaceutical sectors.

    Featured Interviews on Episode #682 Include:

    – DataVault Holdings Inc. (NASDAQ:DVLT)
    CEO Nathaniel Bradley highlights the company’s enterprise expansion, announcing the debut of AI agents powered by IBM watsonx.ai. This breakthrough enables corporate clients to securely monetize data using compliant, intelligent automation. DataVault AI’s growing partnerships with IBM and other tech leaders demonstrate its position at the forefront of AI + Web3 convergence-empowering businesses to unlock value from untapped data assets.

    – PetVivo Holdings Inc. (NASDAQ:PETV)
    PetVivo continues its rapid commercial rollout of SPRYNG with OsteoCushion Technology, now adopted by over 1,200 veterinary clinics across the United States. The company is also making strategic inroads into the equine space through its new partnership with Commonwealth Thoroughbreds-aimed at advancing equine joint wellness and performance across top-tier racing circuits. This milestone reflects PetVivo’s growing leadership in the $3B+ animal therapeutics market, with SPRYNG providing a drug-free, minimally invasive solution to joint pain in companion and performance animals.

    – Health In Tech
    Health In Tech presents its disruptive approach to benefits administration via an end-to-end SaaS platform designed for brokers, employers, and TPAs. The solution’s intuitive interface and real-time quoting tools deliver speed, efficiency, and scalability for today’s healthcare benefits landscape.

    – FLOKI
    Leaders from FLOKI discuss their growing DeFi ecosystem and global presence, with recent expansions into financial education tools, community governance, and real-world payment infrastructure.

    – NRx Pharmaceuticals (NASDAQ:NRXP)
    CEO Dr. Jonathan Javitt offers an update on the company’s late-stage pharmaceutical developments for bipolar depression, PTSD, and other CNS disorders, while continuing to advance FDA engagement for its proprietary pipeline.

    National TV Commercial Support:

    High-frequency national commercials and campaigns are airing in conjunction with the show for:

    • NRx Pharmaceuticals

    • ArriveAI

    • Sustainable Green Team (SGTM)

    • MUSQ – The Music ETF

    Campaigns are focused on national television and the #1 NYC DMA, targeting high-investor-density zones and financial news audiences.

    Cross-Platform Distribution & Outdoor Exposure:

    All interviews are distributed via New to The Street’s YouTube channel (3.1M+ subscribers) and promoted across LinkedIn, Twitter/X, Instagram, and Facebook. Clients also receive billboard exposure across Times Square, Wall Street, and NYC Financial District bus shelters, with additional reach through syndicated earned media on ABC, NBC, and CBS local affiliates.

    July Performance: A Record Month for Client Renewals

    July saw 9 clients signing new or renewed media agreements across broadcast, digital, and outdoor campaigns – driven by demand for New to The Street’s unmatched national visibility and investor engagement platform. These results position the network as the leading multi-channel awareness engine for small- to mid-cap growth companies.

    About New to The Street:
    New to The Street is a premier television business brand broadcasting sponsored programming on Fox Business and Bloomberg Television. With a loyal YouTube following of over 3.1 million subscribers, iconic outdoor billboard access, and strong earned media distribution, New to The Street delivers a 360-degree media solution for public and private companies seeking scale, credibility, and conversion.

    Media Contact:
    Monica Brennan
    Monica@NewToTheStreet.com
    www.NewToTheStreet.com

    SOURCE: New to The Street

    View the original press release on ACCESS Newswire

    The post New to The Street Show #682 Premieres on Bloomberg Tonight Featuring Industry Leaders: DataVault, PetVivo, Health In Tech, FLOKI, and NRx Pharma Backed by National TV Commercials and Outdoor Campaigns Sponsored by MUSQ, ArriveAI, and Sustainable Green Team appeared first on Local News Hub.

  • Williams Hart & Boundas LLP Celebrates 40 Years of Legal Excellence and Community Commitment

    Williams Hart & Boundas LLP Celebrates 40 Years of Legal Excellence and Community Commitment

    HOUSTON, TEXAS / ACCESS Newswire / August 1, 2025 / Williams Hart & Boundas, a nationally recognized personal injury and mass torts law firm based in Houston, proudly announces its 40th anniversary. Since opening its doors in 1985, the firm has remained steadfast in its mission to advocate for individuals and families impacted by catastrophic injuries, defective products, environmental hazards, and corporate negligence.

    Founded on the principles of integrity, compassion, and relentless advocacy, Williams Hart & Boundas LLP has recovered over $24 billion in verdicts and settlements on behalf of thousands of clients nationwide. Over the past four decades, the firm has built a reputation as a legal powerhouse, particularly in representing union workers, injured laborers, and victims of pharmaceutical negligence.

    “Our 40th anniversary is not just a celebration of our legacy, it’s a testament to the trust our clients have placed in us and the results we’ve delivered,” said Managing Partner, John Eddie Williams, Jr. “This milestone reaffirms our commitment to stand up for the hardworking individuals who too often find themselves up against powerful corporations.”

    Williams led the landmark 1998 litigation against Big Tobacco, which resulted in a $17.3 billion settlement for the State of Texas, the largest in U.S. history. Today, he continues to lead mass tort cases and personal injury claims that spotlight corporate negligence and systemic failure.

    The firm’s track record includes landmark victories in asbestos litigation, pharmaceutical mass torts, refinery explosions, and rideshare assault cases. Williams Hart & Boundas LLP is also known for its deep roots in the Houston community, regularly partnering with local organizations, sponsoring educational events, and advocating for workplace safety reforms.

    “As we look ahead, we’re more motivated than ever to innovate, expand access to justice, and protect those who need a strong voice in the legal system,” said Jim Hart, Senior Partner at the firm.

    For more information about Williams Hart & Boundas LLP visit whlaw.com

    ###

    About Williams Hart & Boundas
    Williams Hart & Boundas LLP is a Houston-based law firm with national reach, specializing in catastrophic accident cases. With a long history of trial success and a client-first approach, the firm is dedicated to securing justice for those harmed by negligence. Williams Hart & Boundas LLP brings the resources and perseverance needed to take on insurance companies and multinational corporations alike. The firm offers free case reviews and serves clients nationwide.

    Media Contact:
    Toi C. Ames
    Marketing Strategist
    Phone: (713) 230-2200
    Email: info@whlaw.com
    Website: whlaw.com

    SOURCE: Williams Hart & Boundas LLP

    View the original press release on ACCESS Newswire

    The post Williams Hart & Boundas LLP Celebrates 40 Years of Legal Excellence and Community Commitment appeared first on Local News Hub.

  • CMG Financial’s Colleen Schofield Honored as 2025 HousingWire Insider

    CMG Financial’s Colleen Schofield Honored as 2025 HousingWire Insider

    SAN RAMON, CALIFORNIA / ACCESS Newswire / August 1, 2025 / CMG Financial, one of the nation’s top mortgage lenders, is proud to announce that Colleen Schofield, SVP of Post Closing Operations, has been honored as a 2025 HousingWire Insider. This is Colleen’s second Insider recognition; her first dating back to 2019.

    “The HousingWire Insiders are driving forces behind their organizations’ success,” said Clayton Collins, CEO of HW Media. “These leaders are the architects of operational excellence, transforming strategic vision into tangible results. Reviewing this year’s nominees and winners, it’s clear that HousingWire Insiders deliver results while elevating their colleagues and teams.”

    Colleen Schofield is the quiet force behind CMG’s operational excellence, consistently driving results through strategic foresight, deep institutional knowledge, and a steadfast commitment to integrity. Over the past year, she has played a crucial role in improving internal workflows, enhancing cross-department collaboration, and maintaining the highest standards of compliance and service – all while empowering those around her to succeed. Her calm, solutions-oriented leadership style brings out the best in her team and builds trust across the organization.

    Colleen’s influence extends beyond just operations. She brings steady guidance in times of change, sets a high standard through example, and creates an environment where others can grow and succeed. Her leadership and impact continue to shape CMG’s success from the inside out.

    “Colleen is the kind of leader every organization hopes to have. She’s steady, strategic, and completely selfless in her pursuit of excellence,” notes Susan Walker, CMG’s EVP of Corporate Efficiency. “She doesn’t seek the spotlight, but her impact is felt in every corner of CMG.”

    To read Colleen’s feature in HousingWire and learn more about this year’s honorees, click here.

    About CMG

    CMG Mortgage, Inc. NMLS ID# 1820 (www.nmlsconsumeraccess.orghttp://www.cmghomeloans.com ) is a well-capitalized mortgage lender founded in 1993. Founder and CEO, Christopher M. George, was Chairman of the Mortgage Bankers Association in 2019. CMG makes its products and services available to the market through three distinct origination channels including retail lending, wholesale lending, and correspondent lending. CMG currently operates in all states, including the District of Columbia, and holds approvals with FNMA, FHLMC, and GNMA. CMG is widely known throughout the mortgage banking and housing markets for responsible lending practices, industry and consumer advocacy, product innovation, and operational efficiency.

    About HousingWire

    HousingWire is the most influential source of news and information for the U.S. mortgage and housing markets, boasting a readership that spans lending, servicing, investments, and real estate market participants, as well as financial market professionals. With over 10 million annual unique visitors, HousingWire is the community for mortgage and housing professionals to engage and connect. Industry decision-makers rely on us to Move Markets Forward.

    Media Contact

    Annaugh Madsen
    Phone: (667) 260-6360
    Email: amadsen@cmgfi.com

    .

    SOURCE: CMG Financial

    View the original press release on ACCESS Newswire

    The post CMG Financial’s Colleen Schofield Honored as 2025 HousingWire Insider appeared first on Local News Hub.

  • Atossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

    Atossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

    ORLANDO, FL / ACCESS Newswire / August 1, 2025 / RedChip Companies will air interviews with Calidi Biotherapeutics, Inc. (NYSE American:CLDI) and Atossa Therapeutics, Inc. (Nasdaq:ATOS) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV this Saturday, August 2, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.

    Access the interviews in their entirety at:

    In an exclusive interview, Eric Poma, Ph.D., CEO of Calidi Biotherapeutics, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to discuss Calidi’s pioneering approach to precision genetic medicine, enabled by its proprietary RedTail platform-an engineered, systemically delivered viral therapy designed to reach metastatic sites and deliver genetic medicines to treat tumors. The platform cloaks potent genetic payloads, such as IL-15 superagonist, within a human-derived envelope, allowing the virus to evade immune detection and circulate throughout the body. Preclinical data showcased at AACR and ASCO demonstrated that a single dose of Calidi’s lead candidate, CLD-401, not only eliminated metastatic tumors but also primed immune memory, offering the potential to prevent recurrence. With its scalable, non-integrating viral backbone and ability to deliver multiple genetic payloads, RedTail positions Calidi to address a vast oncology market projected to exceed $560 billion by 2033. The company is advancing toward IND filing in 2026, while exploring strategic pharma partnerships to support global commercialization. Calidi’s capital-efficient business model, strengthened balance sheet, and next-generation pipeline targeting both cancer and autoimmune diseases highlight its strong potential to deliver value to shareholders.

    Dr. Steven Quay, CEO of Atossa Therapeutics, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to discuss Atossa’s strategic approach to redefining breast cancer treatment through its lead clinical candidate, (Z)-endoxifen – a next-generation SERM with best-in-class potential. With a focus on metastatic breast cancer, where current therapies often fall short, Atossa is advancing multiple Phase 2 studies that demonstrate strong clinical activity, improved tolerability, and a favorable safety profile. The presentation will highlight recent progress across key development programs, upcoming milestones, and how the Company’s differentiated science and capital-efficient model are designed to deliver both clinical impact and long-term shareholder value.

    CLDI and ATOS are clients of RedChip Companies. Please read our full disclosure at https://www.redchip.com/legal/disclosures.

    About Calidi Biotherapeutics

    Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage biotechnology company pioneering the development of targeted therapies that can deliver genetic medicines to sites of disease. The company’s proprietary Redtail platform represents a decade of development and expertise in designing viral vectors that can evade immune detection allowing for systemic delivery and distal sites of disease in oncology and, potentially, other indications. This advanced enveloped technology is intended to shield the virus from immune clearance, allowing virotherapy to effectively reach tumor sites, induce tumor lysis, and deliver potent gene therapies to metastatic locations.

    The lead candidate from the Redtail platform, currently in IND-enabling studies, targets non-small cell lung cancer, ovarian cancer, and other tumor types with high unmet medical need. Additionally, Calidi is developing protected virotherapies, in clinical-stage, for intratumoral and localized administration, focusing on a subset of injectable cancer indications.

    Calidi Biotherapeutics is headquartered in San Diego, California. For more information, please visit www.calidibio.com.

    About Atossa Therapeutics

    Atossa Therapeutics, Inc. (Nasdaq:ATOS) is a clinical-stage biopharmaceutical company dedicated to transforming breast cancer treatment through innovative science and patient-focused solutions. The company’s lead product candidate, (Z)-endoxifen, is a highly potent SERM designed for use across the breast cancer spectrum, including prevention, neoadjuvant, adjuvant, and metastatic settings. Atossa is committed to advancing its robust clinical research programs to improve patient outcomes while creating sustainable value for shareholders. For more information, visit atossatherapeutics.com.

    About RedChip Companies

    RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. For 33 years, RedChip has delivered concrete, measurable results for its clients. Our newsletter, Small Stocks, Big Money™, is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, Small Stocks, Big Money™, which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more. RedChip also offers RedChat™, a proprietary AI-powered chatbot that analyzes SEC filings and corporate disclosures for all Nasdaq and NYSE-listed companies, giving investors instant, on-demand insights.

    To learn more about RedChip’s products and services, please visit:

    https://www.redchip.com/corporate/investor_relations

    “Discovering Tomorrow’s Blue Chips Today”™

    Follow RedChip on LinkedIn: https://www.linkedin.com/company/redchip/

    Follow RedChip on Facebook: https://www.facebook.com/RedChipCompanies

    Follow RedChip on Instagram: https://www.instagram.com/redchipcompanies/

    Follow RedChip on Twitter: https://twitter.com/RedChip

    Follow RedChip on YouTube: https://www.youtube.com/@redchip

    Follow RedChip on Rumble: https://rumble.com/c/c-3068340

    Subscribe to our Mailing List: https://www.redchip.com/newsletter/latest

    Contact:

    Dave Gentry
    RedChip Companies Inc.
    1-407-644-4256
    info@redchip.com

    SOURCE: RedChip Companies, Inc.

    View the original press release on ACCESS Newswire

    The post Atossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV appeared first on Local News Hub.